We are live on ! Find out more
ISEE

IVERIC bio

Delisted

ISEE was delisted on the 10th of July, 2023.

48 hedge funds and large institutions have $17.3M invested in IVERIC bio in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.52% less ownership

Funds ownership: 39.75% → 37.23% (-2.5%)

8% less funds holding

Funds holding: 52 → 48 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

93% less capital inflows, than outflows

Capital inflows: $97K | Capital outflows: $1.3M

Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
17
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ISEE Hedge Fund Activity: Q3 2019 in Review

48 of the 4,577 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio (ISEE) for Q3 2019, worth a combined $17.3M — down 18% from $21.2M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ISEE and 4 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $35.6K. The largest seller was Stonepine Capital Management, cutting an estimated $335K.

  • 48 institutional investors held IVERIC bio (ISEE) as of Q3 2019, down from 52 in Q2 2019.
  • Funds reported $17.3M of IVERIC bio stock for Q3 2019, down 18% quarter-over-quarter.
  • 4 funds opened new IVERIC bio positions in Q3 2019 and 8 closed out, a net change of -4 holders.
  • The largest IVERIC bio buyer in Q3 2019 was Vanguard Group, an estimated $35.6K added.
  • The largest IVERIC bio seller in Q3 2019 was Stonepine Capital Management, an estimated $335K sold.

Based on aggregated 13F filings for Q3 2019.